Construction Materials

Cemex SA

Cemex SA released FY2026 Q1 earnings on April 23 During-Market EST, actual revenue USD 4.019 B (forecast USD 3.864 B), actual EPS USD 0.055 (forecast USD 0.113)

Cemex SA to Release FY2026 Q1 Earnings on April 23 During-Market EST, Forecast Revenue USD 3.864 B, EPS USD 0.1135

FactSet Survey: Cementos Mexicanos' 2026 EPS Forecast Median Upgraded to $0.8

Cemex SA released FY2025 Annual Earnings on February 5 During-Market (EST), Actual Revenue: USD 16.13 B (Forecast: USD 16.08 B), Actual EPS: USD 0.6627 (Forecast: USD 0.9405)

Cemex SA released FY2025 Q4 earnings on February 5 During-Market (EST), actual revenue USD 4.18 B (forecast USD 4.012 B), actual EPS USD -0.2453 (forecast USD 0.2026)

Cemex SA to Release FY2025 Q4 Earnings on February 5, 2026 During-Market (EST), Forecast Revenue USD 4.012 B, EPS USD 0.2026

Cemex SA released FY2025 Q3 earnings on October 28 During-Market (EST), actual revenue USD 4.245 B (forecast USD 4.237 B), actual EPS USD 0.1792 (forecast USD 0.1755)

Cemex SA released FY2025 9 Months earnings on October 28 During-Market (EST), actual revenue USD 11.92 B, actual EPS USD 0.5651

Cemex SA to Release FY2025 Q3 Earnings on October 28, Pre-Market EST; Forecast Revenue USD 4.258 B, EPS USD 0.1755

Cemex SA released FY2025 Semi-Annual earnings on July 24 During-Market EST, actual revenue USD 7.775 B, actual EPS USD 0.7128

Cemex SA released FY2025 Q2 earnings on July 24 During-Market (EST), actual revenue USD 4.058 B (forecast USD 4.194 B), actual EPS USD 0.2164 (forecast USD 0.1804)

Cemex SA to release FY2025 Q2 earnings on July 24 During-Market EST, forecast revenue USD 4.188 B, EPS USD 0.1779

FactSet surveys CEMEX's 2025 EPS and revenue forecasts

Cemex SA released FY2025 Q1 earnings during market hours on April 28 (EST), actual revenue USD 3.649 B (forecast USD 3.642 B), actual EPS USD 0.6 (forecast USD 0.0518)

Cemex SA to release FY2025 Q1 earnings report on April 28, pre-market EST, with forecast revenue of USD 3.68 B and EPS of USD 0.0384

Cemex SA released FY2024 earnings on February 6 During-Market (EST), actual revenue 16.2 B USD (forecast 16.79 B USD), actual EPS 0.639 USD (forecast 0.6803 USD)

Cemex SA released FY2024 Q4 earnings on February 6 During-Market (EST), actual revenue $3.811B (forecast $3.854B), actual EPS $0.01 (forecast $0.04)

Cemex SA to Release FY2024 Q4 Earnings on February 6 During-Market EST, Forecast Revenue 3.887 B USD, EPS 0.1433 USD

Cemex SA released FY2024 9 Months Earnings on October 28 Pre-Market (EST), Actual Revenue: USD 12.28 B, Actual EPS: USD 0.5617

Cemex SA released FY2024 Q3 earnings on October 28 Pre-Market (EST), actual revenue 4.09 BUSD (forecast 4.321 BUSD), actual EPS 0.2327 USD (forecast 0.1844 USD)

Micware

Silexion Therapeutics

FLAG SHIP ACQUISITION CORPORATION COM USD0.001 (SUB/RIGHT 31/03/2026)

GCL Global

Linkage Global

Capstone

Jupiter Neurosciences

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

Arcadia Biosciences

UBS Group AG has reduced its stake in Cemex S.A.B. de C.V. by 24.4% during the 4th quarter, now holding 2,891,621 shares valued at approximately $33.2 million. Other institutional investors, including Vanguard Group and CWM LLC, have also adjusted their holdings. Insider Jesus Vicente Gonzalez sold 35,000 shares, decreasing his ownership by 3.97%. Analysts have mixed ratings on Cemex, with a consensus price target of $12.77. The stock opened at $13.12, with a market cap of $19 billion and a P/E ratio of 40.99.

Market Beat

UBS Group AG

JPMorgan Chase

Bank of Nova Scottia

Morgan Stanley

JPMORGAN CHASE & CO. 4.20% DEP SHS REPSTG 1/400TH PFD SER MM

JPMORGAN CHASE & CO. 6%NON CUM DEP SHS REP 1/400TH PFD SER EE

JPMORGAN CHASE & CO. DEP REP 1/400TH (5.75% NON CUM PFD DD)

JPMORGAN CHASE & CO. 4.625% DEP SH RE 1/400TH INT NO CU PF LL

JPMorgan Chase & Co.

JPMORGAN CHASE & CO. 4.55% DEP SHS REPSTG 1/400TH PFD SER JJ

JPMORGAN CHASE & CO. 4.75 DEP SHS REP 1/400 NCUM PFD SR GG

MORGAN STANLEY DEP SHS EA REP 1/1000 SHS NON CUM PFD O

MORGAN STANLEY DEP SHS REPSTG 1/1000TH PFD SER Q

MORGAN STANLEY DEP SHS REPS 1/1000 7.125% PFD E

MORGAN STANLEY NON-CUM DEP SH REP 1/1000 PFD SER I

MORGAN STANLEY 4.875 DEP SHS REP 1/1000 NCUM PFD SR L

MORGAN STANLEY 6.5%DEP SHS REPSTG 1/1000 NON CUM SER P

MORGAN STANLEY DEP SHS REPS 1/1000 PFD SER 'A'

MORGAN STANLEY DEP SHS REPR 1/1000TH INT PFD SER 'F' FX

MORGAN STANLEY DEP SHS REP 1/1000 NON-CUM PFD STK SER K

UBS Group AG Decreases Stake in Cemex S.A.B. de C.V. $CX

Strs Ohio reduced its stake in Cemex S.A.B. de C.V. by 7.7% in Q4, owning 3,953,311 shares valued at $45.42 million. Other institutional investors also adjusted their holdings. Insider Jesus Vicente Gonzalez sold 35,000 shares, decreasing his position by 3.97%. Cemex's stock opened at $12.26, with a market cap of $17.76 billion and a PE ratio of 38.31. The company declared a quarterly dividend of $0.0225 per share, up from $0.02. Analysts have mixed ratings on the stock, with six recommending a Buy and six a Hold.

HSBC Holdings Plc

HSBC HOLDINGS

HSBC

Barclays

HSBC 5xShortSG241213

Strs Ohio Has $45.42 Million Position in Cemex S.A.B. de C.V. $CX

Cemex USA President Jesus Vicente Gonzalez Herrera sold 35,000 shares of Cemex SAB stock for $425,600 on April 29, 2026, marking a significant insider transaction. Following a strong Q1 earnings report and record EBITDA, analysts have raised price targets for Cemex shares, citing improved performance and cash flow. However, uncertainties regarding geopolitical factors and energy costs remain. TipRanks’ AI Analyst rates CX as Outperform, highlighting solid financial recovery and attractive valuation, despite some technical and demand-related risks. Cemex's current market cap is $18.56B with a year-to-date price performance of 5.85%.

Tip Ranks

Top Cemex Executive Makes Attention-Grabbing Move With Company Stock

JPMorgan Chase & Co. has raised its price target for Cemex (NYSE:CX) from $14.00 to $14.50, maintaining an "overweight" rating. This new target suggests a potential upside of 15.03% from the current price. Other firms have also provided ratings, with a consensus of "Moderate Buy" and an average price target of $12.27. Cemex's stock recently traded at $12.61, with a market cap of $18.26 billion. The company reported earnings of $0.16 per share, exceeding estimates, and had revenue of $4.02 billion for the quarter.

ROYAL BANK OF CANADA

Cemex (NYSE:CX) Price Target Raised to $14.50

Cemex (NYSE:CX) reported a record quarterly EBITDA of $794 million for Q1 2026, a 34% year-on-year increase, driven by transformation efforts and strategic initiatives, including asset sales in Colombia and the acquisition of Omega. The company maintains a positive full-year EBITDA guidance despite global uncertainties, focusing on operational efficiency and pricing adjustments. Strong performance was noted in Mexico with a 47% EBITDA growth. Management emphasized energy hedging strategies to mitigate volatility and a commitment to shareholder returns through increased dividends and share buybacks.

benzinga_article

Omega Therapeutics

OMEGA THERAPEUTICS INC

Cemex Q1 2026 Earnings Call: Complete Transcript

Cemex (NYSE:CX) reported quarterly earnings of $0.16 per share, exceeding analysts' expectations of $0.12 by $0.04. The company achieved a net margin of 5.93% and a return on equity of 2.85%. Cemex's stock rose to $12.52, with a market cap of $18.13 billion. The company also increased its quarterly dividend to $0.0225. Analyst ratings show a mix of upgrades and downgrades, with a consensus rating of "Hold" and an average target price of $11.83. Institutional investors own 82.97% of Cemex's stock.

Cemex (NYSE:CX) Releases Quarterly Earnings Results, Beats Expectations By $0.04 EPS

Cemex shares are trading higher after the company reported better-than-expected Q1 financial results.

Invesco Building & Contruction ETF

Cemex reported a solid first quarter with sales rising 11% to $4.02 billion and EBITDA increasing 34% to $794 million. However, net profit fell 69% to $228 million due to a previous year's asset sale. Cement sales volume grew by 1%, while aggregates remained flat and ready-mix concrete volume decreased by 3%. The EBITDA margin improved to 19.8%, attributed to enhanced operational efficiency and a leaner cost structure.

MorningStar

Cemex Reports Solid 1Q Sales, Ebitda Growth

Cemex SA(CX.US)